|
|
| MRD / Regn No. |
: 7216 |
Date |
: 01/06/2026 |
| Patient Name |
: Moumita Goswami |
Age & Gender |
: 47 Yrs. / Female |
| Contact No. |
: 7063301086 |
UHID |
: |
| Ht / Wt / BMI |
: 158 / 94 / 37.65 |
BP S / BP D |
: 152 / 93 |
| Allergies |
: NKA |
Referred By |
: |
| |
|
| Problem
List |
: |
TYPE 2 DIABETES (24/Mar/2021) | HYPERTENSION (24/Mar/2023) | OSA (24/May/2025) | MASLD (24/May/2025) | |
| Salient Investigations |
: |
HBA1C GLYCOSYLATED HEMOGLOBIN: 7.1 % | MICROALBUMIN CREATININE RATIO: 181.2 mcg/mg |
|
|
S# |
Generic (Trade) Name |
Route |
Dosage |
Usage |
Duration |
|
1 |
TELMISARTAN 80 MG
TELVAS |
PO |
0-0-1 |
BEFORE DINNER
|
TILL NEXT VISIT |
|
|
2 |
ATORVASTATIN 20 MG
TONACT 20 MG |
PO |
0-0-1 |
BEFORE DINNER
|
TILL NEXT VISIT |
|
|
3 |
ANTIHYPERGLYCEMIC DAPAGLIFLOZIN 10 MG
APDA 10 MG |
PO |
1-0-0 |
BEFORE BREAKFAST
|
TILL NEXT VISIT |
|
|
4 |
ANTIHYPERGLYCEMIC GLIMIPERIDE 2 MG + METFORMIN 500 MG
GEMER 2 MG |
PO |
1-0-1 |
BEFORE BREAKFAST AND DINNER
|
TILL NEXT VISIT |
|
|
5 |
INJECTION SEMAGLUTIDE 0.25 MG
NOVELTREAT 0.25 |
SC |
ONCE A WEEK |
AFTER BREAKFAST
|
TILL NEXT VISIT |
|
|
| |
|
|
|
| Refill :
0 / Substitution: |
|
|
| Education |
: |
| Next Visit |
: 01/Aug/2026 |
| Tests Suggested For Next Visit |
: HBA1C-HPLC METHOD,UACR:SPOT SAMPLE,FIBROSCAN (CAP & LSM) |
| |
|
| |
|
Dr. Samit Ghosal
MD (GM), Diploma in Diabetes Cardiff University, MSc (Diabetes Care) Glamorgan University, Diploma in Endocrinology Glamorgan University (USW), SCOPE certification in obesity management
West Bengal /
54020
This is a Computer generated Prescription |
Powered By:  |